Atlas Trials

Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS

Clinical trial NCT03459859 · COMPLETED

Trial details

NCT number
NCT03459859
Sponsor
Justin Watts, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAMLAdvanced Myelodysplastic SyndromesMDS
Start date
2018-05-21
Primary completion
2021-06-25
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.